HOLLIS EDEN PHARMACEUTICALS INC /DE/ 4
4 · HOLLIS EDEN PHARMACEUTICALS INC /DE/ · Filed May 18, 2005
Insider Transaction Report
Form 4
WEBER ROBERT W
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2005-05-16$2.25/sh+1,200$2,700→ 18,252 total - Exercise/Conversion
Stock Option (Right to Buy)
2005-05-16−1,200→ 23,800 totalExercise: $2.25Exp: 2006-03-15→ Common Stock (1,200 underlying) - Sale
Common Stock
2005-05-16$8.25/sh−1,200$9,900→ 17,052 total
Holdings
- 7,000(indirect: By Children)
Common Stock
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2004
- [F2]The option vested and became exercisable over a period of three years, and was fully exercisable beginning March 31, 1999.